Cycling-Astana could miss Tour of Beijing after Iglinskiy test

PARIS, Oct 2 (Reuters) - Astana face the prospect of suspending themselves from racing on Thursday after their rider Maxim Iglinskiy failed a test for the banned blood-booster erythropoietin (EPO). The Kazakh-funded team of Tour de France winner Vincenzo Nibali provisionally suspended Iglinskiy after the International Cycling Union (UCI) ruled late on Wednesday that the Kazakh had failed an EPO test on Aug. 1. "In accordance with regulations of the MPCC (Movement for Credible Cycling) to which the Astana team first adhered in 2013, the rider is suspended provisionally and shall remain out of competition in anticipation of the results from the B analysis," Astana team manager Alexandre Vinokourov said in a statement. "All Astana Pro Team riders are contractually obliged to respect strict ethical rules and regulations." MPCC regulations, however, also state that a team must suspend themselves from racing for eight days in the case of multiple positive tests in the past 12 months. Iglinskiy's brother and team mate Valentin was also suspended last month for failing an EPO test in August. Self suspension begins on the first day of the next World Tour race, meaning Astana are set to miss next week's Tour of Beijing, the final race of the UCI World Tour. Astana officials were flying to Almaty on Thursday and were unable to comment. In June last year, French teamn AG2R-La Mondiale sat out of the Dauphine, a prestigious one-week race ahead of the Tour de France after two of their riders had failed dope tests. (Reporting by Julien Pretot; Editing by Patrick Johnston)